Bactiguard’s goal is to create value and generate good returns for the shareholders.
Bactiguards financial targets are to achieve:
- an average growth of 20% per year over a five-year period, with 2020 as the base year;
- an EBITDA margin of at least 30% at the end of the five-year period (year 2025);
- a dividend of 30–50% of profit after tax, taking into consideration the company’s financial position. The company is in an expansion phase and will therefore in the coming years, prioritize growth over dividends.
Bactiguard will continue to expand its operations by strengthening its sales and marketing organization, developing its product portfolio and entering into new licensing agreements in more therapy areas, as well as selective acquisitions.